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Objective:
• To analyze cell viability and metabolic biomarker production of
OCAs stored using the SOC versus the MOPS protocol
Hypothesis:
• OCAs stored using the MOPS system will have significantly higher
cartilage cell viability compared to grafts stored using the current
standard of care at the time of clinical transplantation
• OCAs stored using the current SOC will produce significantly lower
concentrations of anabolic biomarkers and significantly higher
concentrations of inflammatory biomarkers compared to grafts
stored using the MOPS system
Results
Materials and Methods:
With IRB approval, cartilage tissue was collected from OCAs obtained
from tissues banks using the MOPS™ or SOC protocol. For analysis.
MOPS™ grafts were split into groups based on the length of time they
were stored before they were received: day 0, early (<40 days),
intermediate (40-60 days), and late (>60 days). Cartilage was assessed
for viability at the time of collection, and cartilage explants were
cultured for 7 days at 37°C. Media was collected at days 3 and 7 to
assess biomarker concentrations. At day 7 tissues were assessed for
collagen and proteoglycan content.
Discussion:
The production of PGE2, MMP-1, -2, -13, and IL-6 by MOPS™ tissues
in culture was significantly lower than SOC tissues. This indicates that
storage using MOPS™ significantly reduces the production of
inflammatory and degradative enzymes by the tissue. The production of
IL-8 and GRO-α for MOPS™ tissues in culture was significantly higher
than SOC tissues. Previous studies have found a correlation between
increased cartilage viability and production of IL-8 and GRO-α. These
data indicate that tissues stored using the MOPS™ protocol maintains a
normal metabolic response associated with higher tissue viability. The
data from this study indicates that storage using the MOPS™ protocol is
superior for maintaining normal tissue metabolism after transplantation.
Introduction:
Osteoarthritis (OA) affects ~90% of people older than 65, and associated
costs top $100 billion annually in the U.S. One treatment available for
large cartilage defects seen in osteoarthritis is osteochondral allograft
(OCA) transplantation. Currently, tissue banks store OCAs at 4ºC and
implantation is recommended within 28 days after procurement due to
significant loss in chondrocyte viability after this time. Because
mandatory disease screening protocols typically take 14 days to
complete, the window for surgical implantation is narrow, which severely
limits clinical use. The MOPS™ protocol can maintain OCAs for 56
days. In this study, OCAs stored using MOPS™ and SOC protocol were
assessed for cell viability and metabolic biomarker production.
Conclusions
• These data indicate that tissues stored using the MOPS™ protocol maintains a normal metabolic response associated with higher tissue viability. 
• The data from this study indicates that storage using the MOPS™ protocol is superior for maintaining normal tissue metabolism after transplantation.
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Figure 5: The concentration of MMP-1
was significantly higher in MOCA Low
group compared to all MTF groups,
except the MTF Day 0 group, at day 3 of
culture. The concentration of MMP-1
was significantly higher in MOCA High
group compared to the MTF Early and
Intermediate groups at days 3 and 7 of
culture.
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Figure 6: The concentration of MMP-2
was significantly higher in MOCA Low
group compared to the MTF Early and
Intermediate groups at day 3 of culture.
At day 7 of culture, the concentration of
MMP-2 was significantly lower in
MOCA Low group compared to the MTF
Day 0 group and significantly higher
than MTF Late group. The MOCA High
group was significantly higher than the
MTF Early and Intermediate groups at
day 7 of culture.
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Figure 7: The concentration of MMP-13
was significantly higher in MOCA Low
and MOCA High groups compared to the
MTF Day 0 group at culture day 3. At
day 7 of culture, the concentration of
MMP-13 was significantly higher in
MOCA High group compared to all MTF
groups except MTF Day 0 group. There
was no significant difference between the
MOCA Low group and MTF groups at 7
days.
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Figure 1: The concentration of PGE2 in
the MOCA-low group was significantly
higher than all MTF groups at culture
day 3 and all but MTF intermediate at
day 7. The concentration of PGE2 in the
MOCA-high group was significantly
higher than MTF Day 0 and Intermediate
at culture day 3. There was not a
significant difference between MOCA-
high and any of the MTF groups at day 7.
*
0
2
4
6
8
10
12
14
16
18
20
MTF Day 0 MTF Early MTF Intermediate MTF Late MOCA Low
Viability
MOCA High
Viability
IL-6 Concentration (pg/mL)
Culture Day 3 Culture Day 7
*
*
Figure 2: The concentration of IL-6 was
not significantly different between the
MOCA and MTF groups at day 3 of
culture. At day 7 of culture, IL-6 was
significantly lower in MOCA Low group
compared to the MTF Day 0 group, and
significantly higher in MOCA High
group compared to the MTF Early
group.
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Figure 3: The concentration of IL-8 was
significantly lower in MOCA Low and
High groups compared to all MTF
groups at day 3 of culture. At day 7, IL-8
was significantly lower in MOCA Low
group compared to all MTF groups, and
in the MOCA High group compared to
the MTF Late group.
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Figure 4: The concentration of GRO-α
was significantly lower in MOCA Low
group than in the MTF Early and
Intermediate groups, and in the MOCA
High group compared to all MTF groups,
at day 3 of culture. At day 7, GRO-α was
significantly lower in the MOCA Low
group compared to all MTF groups
except for MTF Early, and the MOCA
High group was significantly lower than
the MTF Late group.
